Manchester Keith S's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Nov 21, 2025
- Accession no.
- 0001193125-25-291734
- Filed
- Nov 21, 2025
- Trade date
- Nov 19, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $26.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manchester Keith SCIK 0001244828 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Common Shares | SSaleDisposed | −850,000 | $20.25 | −$17,212,500 | 18,497,727 | Indirect | Duplicate filing |
| Nov 19, 2025 | Common Shares | SSaleDisposed | −150,000 | $20.20 | −$3,030,000 | 18,347,727 | Indirect | Duplicate filing |
| Nov 19, 2025 | Common Shares | SSaleDisposed | −125,000 | $20.16 | −$2,520,000 | 18,222,727 | Indirect | Duplicate filing |
| Nov 19, 2025 | Common Shares | SSaleDisposed | −175,000 | $20.24 | −$3,542,000 | 18,047,727 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.